| Year |
Title |
Altmetric |
| 2019
|
Defining the Hallmarks of Metastasis
2019
|
|
| 2017
|
Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example
2017
|
|
| 2016
|
Increased autophagic response in a population of metastatic breast cancer cells
2016
|
|
| 2016
|
Globular adiponectin enhances invasion in human breast cancer cells
2016
|
|
| 2016
|
SIN3A and SIN3B differentially regulate breast cancer metastasis
2016
|
|
| 2015
|
SOCS3 deficiency in myeloid cells promotes tumor development: Involvement of STAT3 activation and myeloid-derived suppressor cells
2015
|
|
| 2015
|
Promising oncolytic agents for metastatic breast cancer treatment.
2015
|
|
| 2014
|
Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix
2014
|
|
| 2014
|
Linking adiponectin and autophagy in the regulation of breast cancer metastasis
2014
|
|
| 2014
|
Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cells
2014
|
|
| 2014
|
Linking adiponectin and autophagy in the regulation of breast cancer metastasis
2014
|
|
| 2013
|
Mitochondrial Bioenergetics of Metastatic Breast Cancer Cells in Response to Dynamic Changes in Oxygen Tension: Effects of HIF-1α
2013
|
|
| 2013
|
Unraveling the 'TGF-β paradox' one metastamir at a time
2013
|
|
| 2013
|
The C-Terminal Putative Nuclear Localization Sequence of BReast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression
2013
|
|
| 2012
|
Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes
2012
|
|
| 2012
|
Clinical significance of KISS1 protein expression for brain invasion and metastasis
2012
|
|
| 2012
|
Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis
2012
|
|
| 2012
|
The influence of the cancer microenvironment on the process of metastasis.
2012
|
|
| 2011
|
Protein signatures in human MDA-MB-231 breast cancer cells indicating a more invasive phenotype following knockdown of human endometase/matrilysin-2 by siRNA
2011
|
|
| 2011
|
Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression
2011
|
|
| 2011
|
Heparanase-mediated loss of nuclear syndecan-1 enhances Histone Acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype
2011
|
|
| 2011
|
Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines
2011
|
|
| 2011
|
Metastasis suppressors and the tumor microenvironment
2011
|
|
| 2011
|
Metastasis suppressor genes. At the interface between the environment and tumor cell growth
2011
|
|
| 2010
|
Linking metastasis suppression with metastamir regulation
2010
|
|
| 2009
|
Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression
2009
|
|
| 2009
|
Metastamir: The field of metastasis-regulatory microRNA is spreading
2009
|
|
| 2009
|
Linking metastasis suppression with metastamiR regulation
2009
|
|
| 2009
|
Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution
2009
|
|
| 2009
|
Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone
2009
|
|
| 2009
|
Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells
2009
|
|
| 2009
|
Breast cancer metastasis suppressor 1 up-regulates miR-146, Which suppresses breast cancer metastasis
2009
|
|
| 2009
|
Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model
2009
|
|
| 2008
|
Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling
2008
|
|
| 2008
|
Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells
2008
|
|
| 2008
|
BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process
2008
|
|
| 2007
|
A MSC-ing link in metastasis?
2007
|
|
| 2007
|
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy
2007
|
|
| 2006
|
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone
2006
|
|
| 2006
|
Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1)
2006
|
|
| 2006
|
Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases
2006
|
|
| 2005
|
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors
2005
|
|
| 2004
|
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities
2004
|
|
| 2004
|
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
2004
|
|
| 2003
|
The Intermediate S1′ Pocket of the Endometase/ Matrilysin-2 Active Site Revealed by Enzyme Inhibition Kinetic Studies, Protein Sequence Analyses, and Homology Modeling
2003
|
|
| 2002
|
Protein engineering and properties of human metalloproteinase and thrombospondin 1
2002
|
|
| 2001
|
Development and characterization of a new polyclonal antibody specifically against tissue inhibitor of metalloproteinases 4 in human breast cancer
2001
|
|
| 2001
|
Preparation of 2-phenyl-4-(1h-pyrazol-5-yl)quinolines
2001
|
|
| 1999
|
A new series of proton/charge transfer molecules: Synthesis and spectral studies of 2-(5-Aryl-1-carbomethoxy-1H-pyrazol-3-yl)phenols
1999
|
|
| 1999
|
Preparation of N-aryl-4-oxo-4H-1-benzothiopyran-2-acetamides from trilithiated acetoacetanilides and lithiated methyl thiosalicylate
1999
|
|
| 1999
|
The preparation of 2-(1-phenyl-5-phenyl or 5-substituted phenyl-1H- pyrazol-3-yl)phenols from trilithiated 2'-hydroxyacetophenone phenylhydrazone and aromatic esters
1999
|
|
| 1999
|
The preparation of 2-[4,5-dihydro-3-aryl-5-isoxazolyl]-phenols from C(α),O-dilithiooximes and lithiated hydroxyaryl aldehydes
1999
|
|
| 1999
|
The preparation of 4,5-dihydro-2H-benz[e]indazoles from dilithiated 2- tetralone phenylhydrazone and aromatic esters
1999
|
|
| 1998
|
Hydroxyaryl-isoxazoles: Synthesis and related studies
1998
|
|
| 1998
|
A New Preparation of Substituted 4H-1-Benzothiopyran-4-ones from C(α),N-Benzoylhydrazones or C(α),N-Carboalkoxyhydrazones and Methyl Thiosalicylate
1998
|
|
| 1998
|
The preparation of 2-(4-oxo-4h-1-benzopyran-2-yl)- 1-phenylethanones by the condensation/cyclization of dilithiated 1-benzoylacetone with lithiated methyl salicylates
1998
|
|
| 1998
|
The preparation of 4-oxo-N-aryl-4H-1-benzopyran-2-acetamides by the condensation/cyclization of trilithiated acetoacetanilides with lithiated methyl salicylates
1998
|
|
